Vathsala A: Preventing renal transplant failure. Ann Acad Med Singapore. 2005, 34: 36-43.
CAS
PubMed
Google Scholar
Webster A, Ruster L, McGee R, Matheson S, Higgins G, Willis N, Chapman J, Craig J: Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev. 2010, 1: CD003897-
PubMed
Google Scholar
Morris P, Knechtle S: Renal Transplantation: Principles and Practice. 2008, Philadelphia, PA: Saunders
Google Scholar
Hong J, Kahan B: Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol. 2000, 20: 125-108.
Google Scholar
Varon N, Alangaden G: Emerging trends in infections among renal transplant patients. Expert Rev Anti Infect Ther. 2004, 2 (1): 95-109. 10.1586/14787210.2.1.95.
Article
PubMed
Google Scholar
Fortun J, Martin-Davila P, Pascual J: Immunosuppressive therapy and infection after kidney transplantation. Transpl Infec Dis. 2010, 12: 397-405. 10.1111/j.1399-3062.2010.00526.x.
Article
CAS
Google Scholar
Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D, Tallarita T, Zerbo D, Virgilio C, Sciacca A, Cappello D, Stefani S, Veroux P: Infective complications in renal allograft patients: epidemiology and outcome. Transplant Proc. 2008, 40 (6): 1873-1876. 10.1016/j.transproceed.2008.05.065.
Article
CAS
PubMed
Google Scholar
Gu Y, Du J, Ma M: Sirolimus and non-melanoma skin cancer prevention after kidney transplantation: a meta-analysis. Asian Pacific Cancer J. 2012, 13 (9): 4335-4339. 10.7314/APJCP.2012.13.9.4335.
Article
Google Scholar
Piselli P, Serraino D, Segoloni G, Sandrini S, Piredda G, Scolari M, Rigotti P, Busnach G, Messa P, Donati D, Schena F, Maresca M, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F, Immunosuppression and Cancer Study Group: Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009. Eur J Cancer. 2013, 49 (2): 336-344. 10.1016/j.ejca.2012.09.013.
Article
PubMed
Google Scholar
Hricik D: Posttransplant lymphoproliferative disorders: a continued threat for kidney transplant recipients. Am J Kidney Dis. 2011, 58 (6): 870-871. 10.1053/j.ajkd.2011.10.002.
Article
PubMed
Google Scholar
Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou J: Effect of long term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet. 1998, 351: 623-628. 10.1016/S0140-6736(97)08496-1.
Article
CAS
PubMed
Google Scholar
Dantal J, Soulillou JP: Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med. 2005, 13: 1371-1373.
Article
Google Scholar
Canadian Institute for Health Information: Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2001 to 2010. 2011,https://secure.cihi.ca/free_products/2011_CORR_Annua_Report_EN.pdf,
Google Scholar
Lu G, Ades A: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23 (20): 23-20.
Article
Google Scholar
Lumley T: Network meta-analysis for indirect treatment comparisons. Stat Med. 2002, 21 (16): 2313-2324.
Article
PubMed
Google Scholar
Ioannidis J: Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009, 181 (8): 488-493. 10.1503/cmaj.081086.
Article
PubMed
PubMed Central
Google Scholar
Sutton A, Cooper N, Lambert P, Jones D, Abrams K, Sweeting M: Meta-analysis of rare and adverse event data. Expert Rev Pharmacoecon Outcomes Res. 2002, 2 (4): 367-379. 10.1586/14737167.2.4.367.
Article
PubMed
Google Scholar
Sweeting M, Sutton A, Lambert P: What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004, 23 (9): 1351-1375.
Article
PubMed
Google Scholar
Keus F, Wetterslev J, Gluud C, Gooszen H, Laarhoven C: Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials. Am J Gastroenterol. 2009, 104 (3): 545-551.
Article
Google Scholar
Ioannidis J, Lau J: Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001, 285 (4): 437-443. 10.1001/jama.285.4.437.
Article
CAS
PubMed
Google Scholar
Ioannidis J, Lau J: Improving safety reporting from randomised trials. Drug Saf. 2002, 25 (2): 77-84. 10.2165/00002018-200225020-00002.
Article
PubMed
Google Scholar
Jager K, Stel V, Wanner C, Zocalli C, Dekker F: The valuable contribution of observational studies to nephrology. Kidney Int. 2007, 72: 671-675. 10.1038/sj.ki.5002397.
Article
CAS
PubMed
Google Scholar
Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C: An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009, 62 (9): 944-952. 10.1016/j.jclinepi.2008.10.012.
Article
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman D, for the PRISMA group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6 (7): e1000097-10.1371/journal.pmed.1000097. doi:10.1371/journal.pmed.1000097
Article
PubMed
PubMed Central
Google Scholar
Flechner S: Cancer and renal transplantation. Adv Stud Med. 2007, 7 (13): 411-419.
Google Scholar
Quinlan S, Pfeiffer R, Morton L, Engels E, Quinlan S, Pfeiffer R, Morton L, Engels E: Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011, 86 (2): 206-209. 10.1002/ajh.21911.
Article
PubMed
PubMed Central
Google Scholar
Morton M, Coupes B, Roberts S, Klapper P, Byers R, Vallely P, Ryan K, Picton M: Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation. 2013, 95 (3): 470-478. 10.1097/TP.0b013e318276a237.
Article
CAS
PubMed
Google Scholar
Sampaio S, Cho Y, Shah T, Bunnapradist S, Hutchinson I: Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation. 2012, 93 (1): 73-81. 10.1097/TP.0b013e31823ae7db.
Article
CAS
PubMed
Google Scholar
Cockfield S: Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infec Dis. 2001, 3 (2): 70-78. 10.1034/j.1399-3062.2001.003002070.x.
Article
CAS
Google Scholar
Chou R, Aronson N, Atkins D, Ismaila A, Santaguida P, Smith D, Whitlock E, Wilt T, Moher D: Assessing Harms when Comparing Medical Interventions. Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. 2008, Agency for Healthcare Research and Quality: Rockville, MD
Google Scholar
Chou R, Helfand M: Challenges in reviews that assess treatment harms. Ann Intern Med. 2005, 142: 1090-1099. 10.7326/0003-4819-142-12_Part_2-200506211-00009.
Article
PubMed
Google Scholar
Shrier I, Boivin JF, Steele R, Platt R, Furlan A, Kakuma R, Brophy J, Rossignol M: Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007, 166 (10): 1203-1209. 10.1093/aje/kwm189.
Article
PubMed
Google Scholar
Hutton B, Joseph L, Fergusson D, Mazer CD, Shapiro S, Tinmouth A: Risks associated with the use of antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomized and observational studies. BMJ. 2012, 345: e5798-10.1136/bmj.e5798. doi:10.1136/bmj.e5798
Article
PubMed
PubMed Central
Google Scholar
Eddy D, Hasselblad V, Shachter R: Bayesian method for synthesizing evidence: the confidence profile method. Int J Technol Assess Health Care. 1990, 6 (1): 31-55.
Article
CAS
PubMed
Google Scholar
Eddy D, Hasselblad V, Shachter R: An introduction to a Bayesian method for meta-analysis: the confidence profile method. Med Decis Mak. 1990, 10 (1): 15-23. 10.1177/0272989X9001000104.
Article
CAS
Google Scholar
Eddy D, Hasselblad V, Schachter R: Meta-Analysis by the Confidence Profile Method. 1992, San Diego, CA: Academic
Google Scholar
Sutton A, Abrams K: Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001, 10 (4): 277-303. 10.1191/096228001678227794.
Article
CAS
PubMed
Google Scholar
Greenland S, Kheifets L: Leukemia attributable to residential magnetic fields: results from analyses allowing for study biases. Risk Anal. 2006, 26 (2): 471-482. 10.1111/j.1539-6924.2006.00754.x.
Article
PubMed
Google Scholar
Turner R, Spiegelhalter D, Smith G, Thompson S: Bias modelling in evidence synthesis. JR Stat Soc Ser A Stat Soc. 2009, 172 (21): 21-47.
Article
Google Scholar
Wolpert RL, Mengersen K: Adjusted likelihoods for synthesizing empirical evidence from studies that differ in quality and design: effects of environmental tobacco smoke. Stat Sci. 2004, 19 (3): 450-471. 10.1214/088342304000000350.
Article
Google Scholar
Dias S, Sutton A, Welton N, Ades A: NICE DSU Technical Support Document 3: Heterogeneity, subgroups, meta-regression, bias and bias adjustment. 2011,http://www.nicedsu.org.uk,
Google Scholar
Dominici F, Parmigiani G, Wolpert R, Hasselblad V: Meta-analysis of migraine headache treatments: combining information from heterogeneous designs. J Am Stat Assoc. 1999, 94: 16-28. 10.1080/01621459.1999.10473815.
Article
Google Scholar
Dias S, Welton N, Sutton A, Ades A: NICE DSU Technical Support Document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. 2011,http://www.nicedsu.org.uk,
Google Scholar
Schmitz S, Adams R, Walsh C: Incorporating data from various trial designs into a mixed treatment comparison model. Stat Med. 2013, 32: 2935-2949.
Article
PubMed
Google Scholar
Dias S, Welton N, Sutton A, Caldwell D, Lu G, Ades A: NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2011,http://www.nicedsu.org.uk,
Google Scholar
Salanti G, Ades A, Ioannidis J: Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011, 64 (2): 163-171. 10.1016/j.jclinepi.2010.03.016.
Article
PubMed
Google Scholar